ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System. ILC Therapeutics is backed by investors that include Medical Incubator Japan and is headquartered in Newhouse.
INDUSTRY:
Biotechnology, Life Science
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.